Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 74908 |
Drug Identification Number | 02240285 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5ml X10 Vials |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-02-27 |
Actual start date | |
Estimated end date | 2019-05-13 |
Actual end date | 2019-03-18 |
Shortage status | Resolved |
Updated date | 2019-03-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-03-22 | French | Compare |
v6 | 2019-03-22 | English | Compare |
v5 | 2019-03-05 | French | Compare |
v4 | 2019-03-05 | English | Compare |
v3 | 2019-02-28 | English | Compare |
v2 | 2019-02-06 | French | Compare |
v1 | 2019-02-06 | English | Compare |
Showing 1 to 7 of 7